Q2 2023 Acasti Pharma Inc Earnings Call Transcript

Nov 14, 2022 / 06:00PM GMT
Operator

Good day, and welcome to the Acasti Pharma Second Quarter 2023 Earnings Event Call. All participants will be in a listen-only mode. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I'd now like to turn the conference over to Robert Blum with Lytham Partners.

Robert A. Blum - Lytham Partners, LLC - Managing Partner

All right. Thank you very much. Welcome to Acasti Pharma's Second Quarter Fiscal 2023 Conference Call. On the call with us this afternoon is Janelle D'Alvise, President and CEO; Brian Ford, Chief Financial Officer; Monique Champagne, VP of Clinical Affairs; and Prashant Kohli, Chief Commercial Officer. Following management's prepared remarks, there will be a Q&A session. Should any questions remain after the call, please contact me at (602) 889-9700. I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of Canadian securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot